114 related articles for article (PubMed ID: 36549006)
1. Feasibility of using a dual isocentre technique for treating cervical cancer on the 1.5 T MR-Linac.
Chuter RW; Brewster F; Retout L; Cree A; Aktürk N; Hales R; Benson R; Hoskin P; McWilliam A
Phys Med Biol; 2023 Jan; 68(2):. PubMed ID: 36549006
[No Abstract] [Full Text] [Related]
2. Comparison of Intensity Modulated Radiotherapy Treatment Plans Between 1.5T MR-Linac and Conventional Linac.
Ding S; Li Y; Liu H; Li R; Wang B; Zhang J; Chen Y; Huang X
Technol Cancer Res Treat; 2021; 20():1533033820985871. PubMed ID: 33472549
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
4. Brain stereotactic radiosurgery using MR-guided online adaptive planning for daily setup variation: An end-to-end test.
Han EY; Wang H; Briere TM; Yeboa DN; Boursianis T; Kalaitzakis G; Pappas E; Castillo P; Yang J
J Appl Clin Med Phys; 2022 Mar; 23(3):e13518. PubMed ID: 34994101
[TBL] [Abstract][Full Text] [Related]
5. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
Onal C; Efe E; Bozca R; Yavas C; Yavas G; Arslan G
J Appl Clin Med Phys; 2024 Jan; 25(1):e14179. PubMed ID: 38013636
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer.
Hawranko R; Sohn JJ; Neiderer K; Bump E; Harris T; Fields EC; Weiss E; Song WY
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566712
[TBL] [Abstract][Full Text] [Related]
7. CT-guided intensity-modulated radiotherapy for bladder cancer: isocentre shifts, margins and their impact on target dose.
Redpath AT; Muren LP
Radiother Oncol; 2006 Dec; 81(3):276-83. PubMed ID: 17113669
[TBL] [Abstract][Full Text] [Related]
8. Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT.
Heijkoop ST; Langerak TR; Quint S; Bondar L; Mens JW; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):673-9. PubMed ID: 25151538
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implementation and Initial Experience With a 1.5 Tesla MR-Linac for MR-Guided Radiation Therapy for Gynecologic Cancer: An R-IDEAL Stage 1 and 2a First in Humans Feasibility Study of New Technology Implementation.
Lakomy DS; Yang J; Vedam S; Wang J; Lee B; Sobremonte A; Castillo P; Hughes N; Mohammedsaid M; Jhingran A; Klopp AH; Choi S; Fuller CD; Lin LL
Pract Radiat Oncol; 2022; 12(4):e296-e305. PubMed ID: 35278717
[TBL] [Abstract][Full Text] [Related]
10. SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes.
Brennan VS; Burleson S; Kostrzewa C; Godoy Scripes P; Subashi E; Zhang Z; Tyagi N; Zelefsky MJ
Radiother Oncol; 2023 Feb; 179():109441. PubMed ID: 36549340
[TBL] [Abstract][Full Text] [Related]
11. Image guided adaptive external beam radiation therapy for cervix cancer: Evaluation of a clinically implemented plan-of-the-day technique.
Buschmann M; Majercakova K; Sturdza A; Smet S; Najjari D; Daniel M; Pötter R; Georg D; Seppenwoolde Y
Z Med Phys; 2018 Aug; 28(3):184-195. PubMed ID: 29031916
[TBL] [Abstract][Full Text] [Related]
12. Technical Note: Investigating the impact of field size on patient selection for the 1.5T MR-Linac.
Chuter RW; Whitehurst P; Choudhury A; van Herk M; McWilliam A
Med Phys; 2017 Nov; 44(11):5667-5671. PubMed ID: 28869651
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric and feasibility evaluation of a CBCT-based daily adaptive radiotherapy protocol for locally advanced cervical cancer.
Branco D; Mayadev J; Moore K; Ray X
J Appl Clin Med Phys; 2023 Jan; 24(1):e13783. PubMed ID: 36208134
[TBL] [Abstract][Full Text] [Related]
14. Plan-library supported automated replanning for online-adaptive intensity-modulated proton therapy of cervical cancer.
Jagt TZ; Breedveld S; van Haveren R; Nout RA; Astreinidou E; Heijmen BJM; Hoogeman MS
Acta Oncol; 2019 Oct; 58(10):1440-1445. PubMed ID: 31271076
[No Abstract] [Full Text] [Related]
15. MR-linac daily semi-automated end-to-end quality control verification.
Malkov VN; Winter JD; Mateescu D; Létourneau D
J Appl Clin Med Phys; 2023 May; 24(5):e13916. PubMed ID: 36763085
[TBL] [Abstract][Full Text] [Related]
16. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
[TBL] [Abstract][Full Text] [Related]
17. Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans.
van den Wollenberg W; de Ruiter P; Nowee ME; Jansen EPM; Sonke JJ; Fast MF
Med Phys; 2019 Nov; 46(11):5144-5151. PubMed ID: 31529694
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac.
Slagowski JM; Redler G; Malin MJ; Cammin J; Lobb EC; Lee BH; Sethi A; Roeske JC; Flores-Martinez E; Stevens T; Yenice KM; Green O; Mutic S; Aydogan B
Med Phys; 2020 Nov; 47(11):5455-5466. PubMed ID: 32996591
[TBL] [Abstract][Full Text] [Related]
19. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
[TBL] [Abstract][Full Text] [Related]
20. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.
Winkel D; Bol GH; Werensteijn-Honingh AM; Intven MPW; Eppinga WSC; Hes J; Snoeren LMW; Sikkes GG; Gadellaa-van Hooijdonk CGM; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
Radiother Oncol; 2020 May; 146():118-125. PubMed ID: 32146257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
